Skip to main content

Advertisement

SpringerLink
Log in

The carbohydrate-based drug industry

  • Industry Trends
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Whether used as a target or a tool carbohydrates face manufacturing challenges before they can realize their true value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dwek, R.A. 1996. Glycobiology: Toward understanding the function of sugars. Chem. Rev. 96: 683–720.

    Article  CAS  Google Scholar 

  2. Frechet, J.M. and Schuerch, C. 1971. Solid-phase tri-saccharide synthesis. J. Am. Chem. Soc. 93: 492–496.

    Article  Google Scholar 

  3. Bednarski, M. and Simon, E.S. (eds.). 1991. Enzymes in Carbohydrate Synthesis, ACS Series 446. American Chemical Society, Washington, DC.

    Google Scholar 

  4. Borman, S. 1994. Chemical-enzymatic technique used to make carbohydrates, glycopeptides. Chem. Eng. News 72 37–39.

    Google Scholar 

  5. Borman, S. Review & Company Database: Carbohydrate Therapeutics—1997. Edition. ASSETT, e-mail: assettnetor.gr.

  6. Boons, G-T. 1996. Synthetic oligosaccharides: Recent advances. Drug Dev. Today. 1: 331–342.

    Article  CAS  Google Scholar 

  7. Persidis, A. 1995. Enabling technologies and the business of science. Bio/Technology 13: 1172–1176.

    CAS  Google Scholar 

  8. These companies are Alpha-Beta Technology, Biomira, Cytel, Glycomed, Ligand Pharmaceuticals, Martek, Neose Technologies, and Oxford GlycoSciences.

  9. Persidis, A. 1997. Industry trends: Combinatorial chemistry. Nature Biotechnology 15: 391–393.

    Article  CAS  Google Scholar 

  10. Rouhi, M. 1996. Carbohydrates combinatorially. Chem. Eng. News 74: 4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. vice president for business development, Argonex Inc., 2044 India Road, Charlottesville, VA, 22901

    Aris Persidis

Authors
  1. Aris Persidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persidis, A. The carbohydrate-based drug industry. Nat Biotechnol 15, 479–480 (1997). https://doi.org/10.1038/nbt0597-479

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0597-479

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation